Canlyniadau Chwilio - Duncan I. Jodrell
- Dangos 1 - 20 canlyniadau o 43
- Ewch i'r Dudalen Nesaf
-
1
-
2
-
3
-
4
Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect gan Richard L. Hayward, Janet S. Macpherson, Jeff Cummings, Brett P. Monia, John F. Smyth, Duncan I. Jodrell
Cyhoeddwyd 2004Artigo -
5
-
6
<i>nab</i>-Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer gan Kristopher K. Frese, Albrecht Neeße, Natalie Cook, Tashinga E. Bapiro, Martijn P. Lolkema, Duncan I. Jodrell, David A. Tuveson
Cyhoeddwyd 2012Artigo -
7
Optimization of the Antitumor Activity of Sequence-specific Pyrrolobenzodiazepine Derivatives Based on their Affinity for ABC Transporters gan Maciej Kaliszczak, Dyeison Antonow, Katan I. Patel, Philip W. Howard, Duncan I. Jodrell, David E. Thurston, Sylvie M. Guichard
Cyhoeddwyd 2010Artigo -
8
In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer gan Rhona Aird, Jeffrey L. Cummings, Alison Ritchie, Morwenna Muir, Robert E. Morris, H Chen, Peter J. Sadler, Duncan I. Jodrell
Cyhoeddwyd 2002Artigo -
9
-
10
Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine gan Siang‐Boon Koh, Yann Wallez, Charles R. Dunlop, Sandra Bernaldo de Quirós Fernández, Tashinga E. Bapiro, Frances M. Richards, Duncan I. Jodrell
Cyhoeddwyd 2018Artigo -
11
γ-H2AX Foci Formation as a Pharmacodynamic Marker of DNA Damage Produced by DNA Cross-Linking Agents: Results from 2 Phase I Clinical Trials of SJG-136 (SG2000) gan Jenny Wu, Peter H. Clingen, Victoria J. Spanswick, Maria Mellinas‐Gomez, Tim Meyer, Igor Puzanov, Duncan I. Jodrell, Daniel Hochhauser, John A. Hartley
Cyhoeddwyd 2012Artigo -
12
SPARC independent drug delivery and antitumour effects of<i>nab</i>-paclitaxel in genetically engineered mice gan Albrecht Neeße, Kristopher K. Frese, Derek Chan, Tashinga E. Bapiro, William Howat, Frances M. Richards, Volker Ellenrieder, Duncan I. Jodrell, David A. Tuveson
Cyhoeddwyd 2013Artigo -
13
A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma gan Sarah Maria Rudman, Michael B. Jameson, Mark J. McKeage, Philip Savage, Duncan I. Jodrell, Mark Harries, Gary D Acton, Fredrik Erlandsson, James Spicer
Cyhoeddwyd 2011Artigo -
14
CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer gan Albrecht Neeße, Kristopher K. Frese, Tashinga E. Bapiro, Tomoaki Nakagawa, Mark D. Sternlicht, Todd Seeley, Christian Pilarsky, Duncan I. Jodrell, Suzanne Spong, David A. Tuveson
Cyhoeddwyd 2013Artigo -
15
Aspirin activates the NF- B signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer gan Lesley A. Stark, Kenneth GC Reid, Owen J. Sansom, Farhat Din, Sylvie M. Guichard, I. Mayer, Duncan I. Jodrell, Alan R. Clarke, Malcolm G. Dunlop
Cyhoeddwyd 2006Artigo -
16
Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models gan Charles R. Dunlop, Yann Wallez, Timothy Isaac Johnson, Sandra Bernaldo de Quirós Fernández, Stephen T. Durant, Elaine Cadogan, Alan Lau, Frances M. Richards, Duncan I. Jodrell
Cyhoeddwyd 2020Artigo -
17
A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer gan Ian Chau, A. Norman, David Cunningham, Diana Tait, Paul J. Ross, Timothy Iveson, Mark Hill, Tamas Hickish, F. Lofts, Duncan I. Jodrell, Andrew Webb, J. Oates
Cyhoeddwyd 2005Artigo -
18
Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer gan Andrea Saini, A. Norman, David Cunningham, Ian Chau, Mark Hill, Diana Tait, Tamas Hickish, Timothy Iveson, F. Lofts, Duncan I. Jodrell, Paul J. Ross, J. Oates
Cyhoeddwyd 2003Artigo -
19
Depletion of Macrophages Improves Therapeutic Response to Gemcitabine in Murine Pancreas Cancer gan S Buchholz, Robert G. Goetze, Shiv K. Singh, Christoph Ammer‐Herrmenau, Frances M. Richards, Duncan I. Jodrell, Malte Buchholz, Patrick Michl, Volker Ellenrieder, Elisabeth Heßmann, Albrecht Neeße
Cyhoeddwyd 2020Artigo -
20
Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma gan Natalie Cook, Kristopher K. Frese, Tashinga E. Bapiro, Michael A. Jacobetz, Aarthi Gopinathan, Jodi L. Miller, Sudhir Rao, Tim Demuth, William Howat, Duncan I. Jodrell, David A. Tuveson
Cyhoeddwyd 2012Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Medicine
Cancer
Internal medicine
Biology
Cancer research
Pancreatic cancer
Biochemistry
Pharmacology
Immunology
Gemcitabine
Genetics
Chemotherapy
Chemistry
In vivo
Biotechnology
Cell biology
Colorectal cancer
Pharmacokinetics
Immune system
Oncology
Antibody
DNA
Gastroenterology
In vitro
Receptor
Apoptosis
DNA damage
Immunotherapy
Pathology
Regimen